MichaelA.DaviesMD

PubMed

• Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.
  Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, Yvonne A Evrard, Lisa Meier McShane, Michael T Lewis, Kurt W Evans, Dali Li, Lawrence V Rubinstein, Alana L Welm, Den...> ;Molecular Cancer Therapeutics. 2024 Apr 20
• Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma.
  Usman Baqai, Alison M Kurimchak, Isabella V Trachtenberg, Timothy J Purwin, Jelan I Haj, Anna Han, Kristine Luo, Nikole Fandino Pachon, Angela Jeon, Vivian Chua, Micha...> ;The Journal of Biological Chemistry. 2023 Dec 1
• ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.
  Yinshen Wee, Junhua Wang, Emily C Wilson, Coulson P Rich, Aaron Rogers, Zongzhong Tong, Evelyn DeGroot, Y N Vashisht Gopal, Michael A Davies, H Atakan Ekiz, Joshua K H...> ;Biorxiv. 2023 Oct 2
• 2 citations
  Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.
  Russell G Witt, Samuel H Cass, Tiffaney Tran, Ashish Damania, Emelie E Nelson, Elizabeth Sirmans, Elizabeth M Burton, Manoj Chelvanambi, Sarah Johnson, Hussein A Tawbi...> ;JAMA Dermatology. 2023 Oct 1
• 1 citations
  Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.
  Inna Smalley, Adrienne Boire, Priscilla Brastianos, Harriet M Kluger, Eva Hernando-Monge, Peter A Forsyth, Kamran A Ahmed, Keiran S M Smalley, Sherise Ferguson, Michae...> ;Pigment Cell & Melanoma Research. 2024 Jan 1
• Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.
  Erez N Baruch, Priyadahrshini Nagarajan, Frederico O Gleber-Netto, Xiayu Rao, Tongxin Xie, Shamima Akhter, Adebayo Adewale, Islam Shajedul, Brandi J Mattson, Renata Fe...> ;Research Square. 2023 Jul 18
• Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth.
  Anna Han, Dzmitry Mukha, Vivian Chua, Timothy J Purwin, Manoela Tiago, Bhavik Modasia, Usman Baqai, Jenna L Aumiller, Nelisa Bechtel, Emily Hunter, Meggie Danielson, M...> ;Cancers. 2023 Jun 30
• 1 citations
  Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis.
  Ping Yuan, Da Teng, Evelyn de Groot, Man Li, Sebastian Trousil, Che-Hung Shen, Jason Roszik, Michael A Davies, Y N Vashisht Gopal, Bin Zheng> ;Iscience. 2023 Jun 16
• 1 citations
  Diversity, equity, and inclusion in the melanoma research community.
  Marie E Portuallo, David Y Lu, Gretchen M Alicea, Joel Bolling, Rebecca Lee, Jennifer McQuade, Allison Betof Warner, Michael Davies, Ashani Weeraratna, Jessie Villanue...> ;Pigment Cell & Melanoma Research. 2023 Sep 1
• 13 citations
  Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
  Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett Jr, Alexandra P Foster, Ida John, Tarin D Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Det...> ;Nature Medicine. 2023 Apr 1
• 1 citations
  Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
  Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam...> ;Nature. 2023 Mar 1
• 1 citations
  Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.
  Sharmeen Chagani, Mariana P De Macedo, Fernando Carapeto, Feng Wang, Diego M Marzese, Khalida Wani, Lauren E Haydu, Weiyi Peng, Giang T Ong, Sarah E Warren, Joseph M B...> ;The Journal of Investigative Dermatology. 2023 Sep 1
• The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy.
  Apoorvi Chaudhri, Xia Bu, Yunfei Wang, Michael Gomez, James A Torchia, Ping Hua, Shao-Hsi Hung, Michael A Davies, Gregory A Lizee, Ulrich von Andrian, Patrick Hwu, Gor...> ;Frontiers in Immunology. 2023 Jan 1
• 4 citations
  Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
  Merve Hasanov, Denái R Milton, Alicia Bea Davies, Elizabeth Sirmans, Chantal Saberian, Eliza L Posada, Sylvia Opusunju, Jeffrey E Gershenwald, Carlos A Torres-Cabala, ...> ;Neuro-Oncology. 2023 Jul 6
• 5 citations
  Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.
  James S Wilmott, Hussein Tawbi, Johnathan A Engh, Nduka M Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A Vergara, Hansol Lee, Peter A Johansson, Peter M Fergu...> ;Clinical Cancer Research. 2023 Feb 1
• 2 citations
  Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors.
  Jiakai Hou, Shaoheng Liang, Chunyu Xu, Yanjun Wei, Yunfei Wang, Yukun Tan, Nidhi Sahni, Daniel J McGrail, Chantale Bernatchez, Michael Davies, Yumei Li, Rui Chen, S St...> ;NAR Cancer. 2022 Dec 1
• 8 citations
  Body mass index and survival after cancer diagnosis: A pan-cancer cohort study of 114 430 patients with cancer.
  Huakang Tu, Jennifer L McQuade, Michael A Davies, Maosheng Huang, Kunlin Xie, Yuanqing Ye, Wong-Ho Chow, Alma Rodriguez, Xifeng Wu> ;Innovation. 2022 Nov 8
• 99 citations
  Neoadjuvant relatlimab and nivolumab in resectable melanoma.
  Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam...> ;Nature. 2022 Nov 1
• 3 citations
  A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
  Ioana Stejerean-Todoran, Phyllis A Gimotty, Andrea Watters, Patricia Brafford, Clemens Krepler, Tetiana Godok, Haiyin Li, Zuriñe Bonilla Del Rio, Anke Zieseniss, Dörth...> ;Neuro-Oncology. 2023 Apr 6
• 15 citations
  Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
  Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A Nebhan, Ibiayi Dagogo-Jack, Nathaniel J Myall, Georg Richtig, Jillian W P Bracht, Marco Gerlinge...> ;JCO Precision Oncology. 2022 Aug 1
• 4 citations
  Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
  Alcida Karz, Maya Dimitrova, Kevin Kleffman, Christopher Alvarez-Breckenridge, Michael B Atkins, Adrienne Boire, Marcus Bosenberg, Priscilla Brastianos, Daniel P Cahil...> ;Pigment Cell & Melanoma Research. 2022 Nov 1
• 7 citations
  Multi-modal molecular programs regulate melanoma cell state.
  Miles C Andrews, Junna Oba, Chang-Jiun Wu, Haifeng Zhu, Tatiana Karpinets, Caitlin A Creasy, Marie-Andrée Forget, Xiaoxing Yu, Xingzhi Song, Xizeng Mao, A Gordon Rober...> ;Nature Communications. 2022 Jul 9
• 46 citations
  Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
  Jana Biermann, Johannes C Melms, Amit Dipak Amin, Yiping Wang, Lindsay A Caprio, Alcida Karz, Somnath Tagore, Irving Barrera, Miguel A Ibarra-Arellano, Massimo Andreat...> ;Cell. 2022 Jul 7
• 5 citations
  Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.
  Ayal A Aizer, Nayan Lamba, Manmeet S Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K Brastianos, Paul D Brown, D Ross Camidge, Veronica L Chiang, Michael A Davi...> ;Neuro-Oncology. 2022 Oct 3
• 14 citations
  Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.
  Christopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, Naema Nayyar, Matt Lastrapes, Matthew R Strickland, Albert E Kim, Magali de Sauvage, Ashish Dah...> ;Cancer Immunology Research. 2022 Aug 3
• Join now to see all

Journal Articles

• Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
  Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
• Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
  Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
• Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
  Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
• Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic Melanoma  
  M T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology
• Profiles of Brain Metastases: Prioritization of Therapeutic Targets  
  Raymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
• Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell Populations  
  Zeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research
• ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma  
  Michael A Davies, Jeffrey E Gershenwald, Clinical Cancer Research
• Join now to see all

Lectures

• Will Targeted Therapy Replace Radiation for Melanoma Brain Metastases? 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
• 17th Perspectives In Melanoma 
  Imedex, Baltimore, Maryland - 9/13/2013